BQ-788

Star0

DB17984InvestigationalSmall molecule

BQ-788: Overview.

Formula / weight: C₃₄H₅₀N₅NaO₇ · 663.792 g/mol (avg)
Also known as: D-norleucine, n-(((2r,6s)-2,6-dimethyl-1-piperidinyl)carbonyl)-4-methyl-l-leucyl-1-(methoxycarbonyl)-d-tryptophyl-, sodium salt (1:1)
Code names: BQ-788 · ENB-001

Resolves to

Compound

UNII44OLL8XEJ4CAS156161-89-6ChEMBLCHEMBL1515091

Structure

InChIKeyQCVIFBRTTLMEOV-FUKQNADPSA-MSMILES[Na+].CCCC[C@@H](NC(=O)[C@@H](CC1=CN(C(=O)OC)C2=CC=CC=C12)NC(=O)[C@H](CC(C)(C)C)NC(=O)N1[C@@H](C)CCC[C@H]1C)C([O-])=O

Targets

P24530EDNRB

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with BQ-788, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account